Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Peavalu mõju test-6× | Dermatology Life Quality Index× | |
|---|---|---|
| Valdkond | Tervisetulemid | Tervisetulemid |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 2003 | 1994 |
| Looja≠ | Mark Kosinski et al. | Andrew Y. Finlay and Gul K. Khan |
| Tüüp≠ | Self-report functional impact questionnaire | Self-report quality of life questionnaire |
| Algallikas≠ | Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974. DOI ↗ | Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216. DOI ↗ |
| Rööpnimetused | HIT-6, Headache Impact Test, HIT | DLQI, Finlay Index, Dermatology Quality of Life |
| Seotud≠ | 4 | 3 |
| Kokkuvõte≠ | The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit. | The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology. |
| ScholarGateAndmestik ↗ |
|
|